Development
Predictive Oncology Inc.
POAI
$0.9386
-$0.0114-1.20%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -18.42M | -19.32M | -25.79M | -25.74M | -25.58M |
| Total Depreciation and Amortization | 913.70K | 1.08M | 1.23M | 1.31M | 1.35M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 0.00 |
| Total Other Non-Cash Items | 4.01M | 4.01M | 11.01M | 11.19M | 11.07M |
| Change in Net Operating Assets | 159.30K | 1.28M | 847.10K | 866.80K | 277.00K |
| Cash from Operations | -13.34M | -12.95M | -12.70M | -12.37M | -12.88M |
| Capital Expenditure | -341.70K | -466.10K | -398.90K | -419.90K | -557.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -9.59M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -31.60K | -46.90K | -43.20K | -55.70K | -51.30K |
| Cash from Investing | -373.20K | -513.00K | -442.10K | -475.70K | -10.20M |
| Total Debt Issued | 364.70K | -- | -- | -- | -- |
| Total Debt Repaid | -104.50K | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 0.00 | 0.00 | 6.66M | 6.74M | 6.83M |
| Repurchase of Common Stock | -23.60K | -27.60K | -27.60K | -27.60K | -4.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -124.50K |
| Cash from Financing | 236.60K | -27.60K | 6.63M | 6.72M | 6.70M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -13.48M | -13.49M | -6.52M | -6.13M | -16.38M |